AP
AVLN

Andera Partners’s Avalyn Pharma AVLN Stock Holding History

Andera Partners’s Portfolio AVLN Stock Details AVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6M Buy
+929,824
New +$26.8M 14.82% 3

Other funds holding AVLN

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Andera Partners's AVLN Position: Q2 2026 in Review

Andera Partners opened a new position in Avalyn Pharma (AVLN) in Q2 2026: 929,824 shares worth $30.6M. The stake represents 14.82% of the portfolio and ranks #3 among its holdings.

11 funds tracked by Wall St. Rank hold AVLN as of Q2 2026.

  • Andera Partners held 929,824 shares of Avalyn Pharma worth $30.6M as of Q2 2026.
  • Avalyn Pharma was a new Andera Partners position in Q2 2026.
  • Avalyn Pharma made up 14.82% of Andera Partners's portfolio in Q2 2026, its #3 holding.
  • 11 funds tracked by Wall St. Rank held Avalyn Pharma as of Q2 2026.

Based on Andera Partners's 13F filing for Q2 2026, filed 22 Jul 2026.